Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

DOCS vs VEEV: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VEEV Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–3 Matrix Metrics)

VEEV Overall Winner 6-Pillar Tally: DOCS 3 – 3 VEEV Matrix Metrics: DOCS 3 – 7 VEEV

As of Nov 17, 2026, Veeva Systems Inc. (VEEV) is the stronger overall head-to-head candidate over Doximity, Inc. (DOCS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). DOCS carries a Unified Composite Score of 56.2/100 (HOLD) at $31.25 (20.2x Forward P/E, 27.1% operating margin), whereas VEEV carries 48.5/100 (HOLD) at $290.25 (34.8x Forward P/E, 29.9% operating margin).

  • Composite vs. Pillar Nuance: While DOCS currently prints a higher short-term Unified Composite Score (56.2/100 HOLD vs. VEEV 48.5/100 HOLD), VEEV captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (29.9% vs. 27.1% operating margin) and revenue trajectory (+17.6% vs. +3.6% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About DOCS vs VEEV
DOCS NYSE
Doximity, Inc.
Services-Computer Programming Services
$31.25
-4.62% 1D
Market Cap $5.9B
TTM Revenue $662M
Forward P/E 20.2x
Beta / 30D Vol 0.68β · 42% Vol
Unified Composite Score
56.2 / 100 HOLD
Tech 40.0 Fund 51.0 Flow 58.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 46.3 · SMA20: $33.13 · SMA50: $30.00
VEEV NYSE Head-to-Head Winner
Veeva Systems Inc.
Services-Prepackaged Software
$290.25
-3.02% 1D
Market Cap $48.8B
TTM Revenue $3.46B
Forward P/E 34.8x
Beta / 30D Vol 0.39β · 20% Vol
Unified Composite Score
48.5 / 100 HOLD
Tech 45.0 Fund 53.0 Flow 68.0 Mom 46.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 41
RSI-14: 40.9 · SMA20: $309.35 · SMA50: $292.48

6-Pillar Scorecard Institutional Category Breakdown (DOCS 3 – 3 VEEV)

Columns: Metric · DOCS · VEEV
1. Valuation Multiples DOCS
Forward P/E 20.2x 34.8x
Trailing P/E 46.3x 49.4x
PEG Ratio 0.59x 1.16x
EV / Revenue 8.7x 13.6x
2. Growth & Scale VEEV
Revenue Growth (YoY) +3.6% +17.6%
Earnings Growth (YoY) -41.9% +39.5%
TTM Revenue (USD) $662M $3.46B
Market Cap $5.9B $48.8B
3. Profitability & Quality VEEV
Gross Margin 86.8% 75.0%
Operating Margin 27.1% 29.9%
Net Profit Margin 21.1% 29.3%
Return on Equity (ROE) 13.8% 14.4%
4. Balance Sheet & Cash Flow VEEV
Cash Generation (TTM) $297M $1.67B
Cash Flow Margin 44.9% 48.2%
Net Cash / Leverage $209M Net Cash $1.66B Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning DOCS
Options Structure Phase SURGE CONSOLIDATION
Current IV / %ile 42.5% (33rd %ile) 45.0% (55th %ile)
Put/Call OI Skew 0.25x (Call-Skewed) 0.71x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat DOCS
OpEx & R&D Intensity 59.7% of Rev ($395M) 45.1% of Rev ($1.56B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Health Information Services Operator Health Information Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: DOCS (3) vs VEEV (7)
Institutional Metric DOCS VEEV Criterion Row Edge
Market Capitalization
Scale
$5.9B $48.8B Larger Scale VEEV
Trailing P/E Ratio
Valuation
46.3x 49.4x Lower Multiple DOCS
Forward P/E Ratio
Valuation
20.2x 34.8x Lower Multiple DOCS
Revenue Growth (YoY)
Growth
+3.6% +17.6% Higher Growth VEEV
Operating Margin (TTM)
Profitability
27.1% 29.9% Higher Margin VEEV
Net Profit Margin
Profitability
21.1% 29.3% Higher Margin VEEV
Return on Equity (ROE)
Capital Efficiency
13.8% 14.4% Higher ROE VEEV
52-Week Range Position
Momentum
41% ($17–$52) 80% ($148–$326) Stronger Trend VEEV
Beta / 30D Volatility
Risk Regime
0.68β · 42% Vol 0.39β · 20% Vol Lower Realized Risk VEEV
Unified Institutional Score
Composite Signal
56.2 / 100 (HOLD) 48.5 / 100 (HOLD) Higher Composite DOCS
Trailing 12M Revenue (USD)
Operating Scale
$662M $3.46B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
86.8% 75.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.59x PEG · 8.7x EV/Rev 1.16x PEG · 13.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$297M ($209M Net Cash) $1.67B ($1.66B Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon DOCS +7.76 pp
DOCS: -0.62% · VEEV: -8.38%
3M Horizon DOCS +5.74 pp
DOCS: +21.38% · VEEV: +15.64%
6M Horizon VEEV +15.45 pp
DOCS: +62.28% · VEEV: +77.73%
1Y Horizon VEEV +35.95 pp
DOCS: -37.01% · VEEV: -1.06%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period DOCS Revenue VEEV Revenue DOCS Op. Margin VEEV Op. Margin Margin Leader
FY2019 N/A $860M N/A 25.8% VEEV
FY2020 $120M $1.10B 19.0% 25.9% VEEV
FY2021 $210M $1.47B 25.8% 25.8% Tie
FY2022 $340M $1.85B 33.0% 27.3% DOCS
FY2023 $420M $2.16B 29.9% 21.3% DOCS
FY2024 $480M $2.36B 34.5% 18.2% DOCS
FY2025 $570M $2.75B 39.9% 25.2% DOCS
FY2026 $640M $3.20B 33.3% 28.7% DOCS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
DOCS SURGE
14d in phase · OBV NEUTRAL
Current IV 42.5%
IV Percentile 33rd %ile
Put/Call OI Skew 0.25x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact DOCS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VEEV CONSOLIDATION
55d in phase · OBV DISTRIBUTION
Current IV 45.0%
IV Percentile 55th %ile
Put/Call OI Skew 0.71x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact VEEV Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $32.77 · IV 42.9%

DOCS vs. VEEV: Simulated 5-Day Option Payoffs & Capital Efficiency

Compare 100 shares of DOCS ($3,277) vs. VEEV ($29,928) against risk-defined 5-day vertical and put-wall option structures.

DOCS Spot $32.77 · IV 42.9%
DOCS Options Simulator →
5-DAY BULLISH SWING Liq B

Dec 18 $32.5 / $35 Bull Call Spread

Buy 1x $32.5C · Sell 1x $35C · 32d

Net Entry $90 Debit
T+5d @ +5% Move +$41 (+46%)
Max Risk / Buffer $90 Capped
5d Edge & Liquidity 0.9x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Dec 18 $30 / $27.5 Bull Put Spread

Sell 2x $30P · Buy 2x $27.5P · 32d

Net Entry $58 Credit
Max Credit / Yield +$58 (+13.1% RoM)
Max Risk / Buffer -9.3% Cushion ($442 Mgn)
5d Edge & Liquidity 79% PoP · Liq B
Simulate 5-Day Payoff →
VEEV Spot $299.28 · IV 50.8%
VEEV Options Simulator →
5-DAY BULLISH SWING Liq B

Dec 18 $300 / $330 Bull Call Spread

Buy 1x $300C · Sell 1x $330C · 32d

Net Entry $1,140 Debit
T+5d @ +5% Move +$352 (+31%)
Max Risk / Buffer $1,140 Capped
5d Edge & Liquidity 0.8x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Dec 18 $280 / $260 Bull Put Spread

Sell 1x $280P · Buy 1x $260P · 32d

Net Entry $478 Credit
Max Credit / Yield +$478 (+31.4% RoM)
Max Risk / Buffer -8.0% Cushion ($1,522 Mgn)
5d Edge & Liquidity 71% PoP · Liq B
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
DOCS Moat Profile Scale & Operating Efficiency Moat
Health Information Services Operator
Competes within the Health Information Services value chain with $5.9B market capitalization and 27.1% operating margin.
OpEx & R&D Reinvestment 59.7% of Rev ($395M)
90D Engineering Disclosures 0 Published
VEEV Moat Profile Scale & Operating Efficiency Moat
Health Information Services Operator
Competes within the Health Information Services value chain with $48.8B market capitalization and 29.9% operating margin.
OpEx & R&D Reinvestment 45.1% of Rev ($1.56B)
90D Engineering Disclosures 0 Published

Investor FAQ DOCS vs VEEV Key Questions & Quantitative Answers

As of Nov 17, 2026, Veeva Systems Inc. (VEEV) is the stronger overall head-to-head candidate over Doximity, Inc. (DOCS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). DOCS carries a Unified Composite Score of 56.2/100 (HOLD) at $31.25 (20.2x Forward P/E, 27.1% operating margin), whereas VEEV carries 48.5/100 (HOLD) at $290.25 (34.8x Forward P/E, 29.9% operating margin). Composite vs. Pillar Nuance: While DOCS currently prints a higher short-term Unified Composite Score (56.2/100 HOLD vs. VEEV 48.5/100 HOLD), VEEV captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (29.9% vs. 27.1% operating margin) and revenue trajectory (+17.6% vs. +3.6% YoY).

VEEV leads the Growth & Scale pillar: DOCS posts +3.6% YoY revenue growth and -41.9% YoY earnings growth on $662M TTM revenue (86.8% gross margin, 27.1% operating margin), compared with VEEV at +17.6% YoY revenue growth and +39.5% YoY earnings growth on $3.46B TTM revenue (75.0% gross margin, 29.9% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), DOCS cumulative revenue shifted +433.3% while VEEV shifted +272.1%. In operating R&D and SG&A reinvestment, DOCS deploys 59.7% of Rev ($395M) (0 90-day corporate R&D disclosures) versus 45.1% of Rev ($1.56B) (0 disclosures) for VEEV.

DOCS screens cheaper on headline valuation multiples. DOCS trades at 20.2x Forward P/E, 46.3x Trailing P/E, 0.59x PEG, and 8.7x EV/Revenue (44.9% FCF margin), whereas VEEV trades at 34.8x Forward P/E, 49.4x Trailing P/E, 1.16x PEG, and 13.6x EV/Revenue (48.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DOCS (13.8% ROE) versus VEEV (14.4% ROE) capital efficiency.

In options market volatility and institutional positioning, DOCS carries 42.5% implied volatility (33rd %ile, Balanced (25th–60th %ile)), a 0.25x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (0.68β · 42% Vol realized risk). By comparison, VEEV carries 45.0% implied volatility (55th %ile, Balanced (25th–60th %ile)), a 0.71x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.39β · 20% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.